FDA News Release Companies Must Stop Marketing Unauthorized Products or Risk Enforcement For Immediate Release: November 16, 2022 Today, the U.S. Food and Drug Administration issued warning letters to five firms for the unauthorized marketing of 15 …
For Immediate Release: November 15, 2022 English Hari ini, Badan Pengawas Obat dan Makanan AS mengumumkan kemajuan yang belum pernah terjadi sebelumnya dalam pencegahan penyakit yang ditularkan melalui makanan melalui finalisasi aturan untuk melacak …
For Immediate Release: November 15, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an Emergency Use Authorization (EUA) to Roche Molecular Systems, Inc. for the …
For Immediate Release: November 15, 2022 Today, the U.S. Food and Drug Administration announced an unprecedented advancement in foodborne illness prevention through the finalization of a rule to more effectively trace contaminated food through the food …
FDA News Release Agency Continues to Encourage Sponsor Applications for Over-the-Counter Naloxone Products For Immediate Release: November 15, 2022 Agency Continues to Encourage Sponsor Applications for Over-the-Counter Naloxone Products Today, the U.S. …
For Immediate Release: November 15, 2022 Today, the U.S. Food and Drug Administration conditionally approved Panoquell-CA1 (fuzapladib sodium for injection) for the management of clinical signs associated with acute onset of pancreatitis in dogs. Panoquell …
For Immediate Release: November 14, 2022 Today, the U.S. Food and Drug Administration is providing an update on additional steps it has taken that will lead to more infant formula available in the U.S. under the agency’s increased flexibilities. Company ( …
For Immediate Release: October 28, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA updated the list of Breakthrough Devices that have been authorized for marketing. The …
For Immediate Release: October 26, 2022 Today, the U.S. Food and Drug Administration issued marketing denial orders (MDOs) for several e-cigarette products currently marketed by Logic Technology Development LLC (Logic). The currently marketed products …
For Immediate Release: October 25, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued a Safety Communications warning consumers, caregivers and health care …
For Immediate Release: October 17, 2022 English Hoy, el Departamento de Justicia (DOJ, por sus siglas en inglés), en nombre de la Administración de Alimentos y Medicamentos de EE. UU., solicitó prohibiciones permanentes en los tribunales federales de …
For Immediate Release: October 21, 2022 FDA Roundup: October 21, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA issued a draft guidance, “Select Updates for the …
For Immediate Release: October 18, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Tuesday, the FDA issued an emergency use authorization (EUA) for the first over-the-counter …
For Immediate Release: October 18, 2022 Today, the U.S. Department of Justice (DOJ), on behalf of the U.S. Food and Drug Administration, filed complaints for permanent injunctions in federal district courts against six e-cigarette manufacturers. These …
For Immediate Release: October 17, 2022 Today, the U.S. Food and Drug Administration announced it has awarded 19 new grants and two new contracts totaling more than $38 million in funding over the next four years to support clinical trials, natural history …
For Immediate Release: October 14, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the FDA Voices: “FDA Seeks Feedback on Distributed and Point-of-Care Drug …
For Immediate Release: October 12, 2022 Today, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) of the Moderna COVID-19 Vaccine, Bivalent and the Pfizer-BioNTech COVID-19 Vaccine, Bivalent to authorize their use as a …
For Immediate Release: October 11, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: • Today, the FDA announced the launch of an independent study by the National Academies of Sciences, …
For Immediate Release: September 30, 2022 Today, the U.S. Food and Drug Administration published guidance that will help provide a pathway for infant formulas operating under enforcement discretion in the U.S. to remain on the market. This will help ensure …
For Immediate Release: September 30, 2022 Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA published the FDA Voices: “FDA Continues Important Work on Substance Use and Overdose …
06 days 10:17:11
